Medicine shortages and strategic healthcare autonomy in the EU

This procedure addresses the growing concern of medicine shortages within the EU. It aims to strengthen the European pharmaceutical sector and ensure a stable supply of essential medicines for citizens, enhancing the EU's strategic autonomy in healthcare.

It will affect patients, healthcare providers, and the pharmaceutical industry. The goal is to improve access to medicines and build resilience against future supply chain disruptions.